T. rangeli11 2 3 or leishmanial infections1213,has been reported many areas of Central and South America. As there are important antigenic cross-reactivities between these different parasites3 8 the use of classical serological tests for the diagnosis of Chagas'disease becomes ineffective in these coendemic areas. In an attempt to gain better specificity for diagnosis, several technical approaches have been used9 1 0 1 4 2 1 22 .
In previous studies, Afchain et al3 have identi fied a species-specific antigen called component 5, in the T. cruzi parasite. Recently, by using murine mono clonal antibodies directed against this component1819, Lemesre et al16 proposed a competitive enzyme immunoassay (CEIA) for the specific diagnosis of Chagas'disease. The purpose of the present work was to use the CEIA to investigate anti-component 5 antibodies in sera of dogs, rabbits, opossums and rats infected with T. cruzi and to compare it with that find in patients with American trypanosomiasis.
MATERIALS A ND M ETHODS

Animal sera
Twenty-eight mongrel dogs of both sexes, 2-5 months old, were inoculated intraperitoneally with 4-6 x 105 T. cruzi trypomastigotes of the 12SF strain per kg of body weight as described by Andrade et after inoculation and sera were collected at different times of both the acute and the chronic phase of the infection. Although parasitaemia became negative at the chronic stage, xenodiagnosis and/or the comple ment fixation test remained positive for all animals. A total of 40 serum samples of infected dogs was used in this study. The sera from 14 dogs before inoculation were used as control. Thirteen New Zealand white rabbits, weighing 1200-1500 g, were inoculated intraperitoneally with 107 blood stream forms of T. cruzi (12 SF strain) per kg of body weight Parasitaemias in the acute phase, and positive xenodiagnosis and indirect immunofluores cence in the chronic phase confirmed the infection. A total of 24 serum samples collected at several times after inoculation was used in this study. Seven pre inoculation sera from the same rabbits were used as control.
Fifteen male Fischer rats, weighing 180-200 g were inoculated intraperitoneally with 1 ml heparinized rat blood containing 104 T. cruzi trypomastigotes of the Tehuantepec strain as described by Rodriguez et al20. The infection was monitored by the presence of parasites in the blood and by a positive passive hemagglutination test19. A total of 15 serum samples was collected at different times after infection. The sera from 8 normal Fischer rats were used as control.
The sera from 25 opossums (Didelphis albiventris), captured in an endemic area for Cha gas'disease (Castro Alves, Bahia state, Brazil) have also been studied. Twelve were naturally infected with T. cruzi as confirmed by a positive xenodiagnosis. The sera from 14 opossums, captured in a non-endemic area for Chagas'disease (Jacobina, Bahia state, Bra zil) and with a negative xenodiagnosis, were used as control. Two of them showed a positive culture for Leishmania spp. Tropical 20: 91-94, Abr-Jun, 1987. 
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Human sera
The sera from 51 Venezuelan patients with chronic Chagas'disease and a positive serology for T.
cruzi (immunofluorescence, complement fixation test, hemagglutination and ELISA) were generously provi ded by Dr. Rosa M. Mubsch, Universidad de Carabobo, Facultad de Ciencias de la Salud, Maracay, Venezuela. Control sera were obtained from 20 healthy subjects with a negative serology for T. cruzi.
Monoclonal antibody (mAb)
Hybridomas secreting mAb against component 5 has been described by Orozco etal18 19. Ascitic fluid were produced in Balb/c mice and the mAb (II-190/30) was purified by a 50% ammonium sulfate precipitation followed by a ion exchange chromato graphy on DEAE-Trisacryl (IBF, Villeneuve la Garenne, France). Labelling of purified mAb with alka line phosphatase (grade I from calf intestine, Boehringer, Mannheim, W est Germany) was performed by the one-step glutaraldehyde method of Avrameas5. Briefly: to 5mg of enzyme were added 1ml of the mAb solution (2 m g/m l) and 1 0 /xl of 2 0 % glutaraldehyde solution. The mixture was allowed to react for 2 h at room temperature and then dialysed against PBS.
Competitive antibody enzyme immunoassay (CEIA)
It was performed as described by Lemesre et al16. Briefly, polypropylene beads (Seroa, Monaco) were coated overnight at room temperature with a compo nent 5-enriched T. cruzi antigen. After 3 washes in PBS containing 0.1% Tween 20, the beads were incubated for 2 hr with PBS-0.1% bovine serum albumin, washed 3 times with PBS-Tween and once with PBS. CEIA was carried out in disposable polys tyrene tubes. Coated beads were incubated for 3 hr at 37°C in 350 ju.1 of PBS containing the labeled mAb (final dilution 1/800) and the test sera (final dilution 1/20). After 3 washes in PBS-Tween, the beads were transfered to another tube and the labelled antibody fixed to them was revealed by adding 300 ju.1 of the enzyme-substrate (1 mg/ml 4-paranitrophenylphosphate in 0.5 M N a2 C 0 3 , 0.001 M M gC l2 buffer pH 10.4). After contact for one hour at 37° C, the colour development was stopped by adding 300 ju.1 NaOH 2N and absoibance was measured at 405 nm. As the C EIA involves the competitive inhibition of binding of alkaline phosphatase-conjugated mAb by anti-com ponent 5 antibodies present in test sera low extinction values indicate a positive result
Immunoelectrophoresis
The presence of anti-component 5 antibodies in sera of some animals infected with T. cruzi was also investigated by immunoelectrophoresis as described by Afchain et al1.
RESULTS
The presence of anti-component 5 antibodies in sera of dogs, rabbits, rats and opossums infected with T. cruzi was investigated by the competitive antibody enzyme immunoassay (CEIA) with enzyme-conjuga ted anti-component 5 mAb (Fig. 1) positivity for each animal species studied was calcula ted in each control group as the mean subtracted of twice the standard deviation. The results were then slighdy corrected in order to have the same cut-off value as that observed with normal human sera. Therefore, the data obtained for each group of animals infeted with T. cruzi could be compared in the same Figure 1 with the results from the patients with Chagas'disease (positive control). In these conditions, anti-component 5 antibodies were not detected in sera of dogs, rats and opossums infected with T. cruzi. In fact, only 4 out of 40 sera of dogs, 1 out of 13 opossums with negative xenodiagno sis, and 3 out of 15 sera of rats showed significant results which were near the limit of positivity. In the group of rabbits infected with T. cruzi, about the half of the tested sera presented a significant positive value, but most of them was closed to the limit of positivity. There was no association between these results and the phase of the infection.
To analyse further the presence of anti-compo nent 5 antibodies in experimental Chagas'disease, the sera of the infected animals showing a significant result in the CEIA were tested by immunoelectrophoresis against a crude antigenic extract of T. cruzi. Although most of the sera from infected animals recognised different components in the T. cruzi extract, none of them reacted with the component 5 (data not shown).
DISCUSSION
A previous study demonstrated that more than 90% of patients with Chagas'disease presented signi ficant high levels of anticomponent 5 antibodies16. In the present investigation, by using the same methodo logy, the CEIA with enzyme-conjugated mAb we have confirmed these findings in another group of patients but failed to detect significant levels of anti-component 5 antibodies in dogs, rats, opossums and rabbits infected with T. cruzi.
The interest in component 5 begun when Afchain et al1 showed that this antigen represents one of the major immunoelectrophoretic lines recognized by the sera of most of the patients with Chagas'disease. Furthermore, it has been demonstrated that compo nent 5 is a species-specific antigen of T. cruzi2. The generation of mAb against this antigen allowed the identification of a 72,000 M r glycoprotein and its maturation products o f51,000,43,000 and 24,000 Mr as the molecules containing the antigenic determinants of component 519. In order to avoid the crossreactivities frequently observed between T. cruzi and others trypanosomatidae3 8, Breniere et al7 and Lemesre et al1 6 have successfully used different techni ques to detect anti-component 5 antibodies in sera of patients infected with T. cruzi. These methods have proved to be useful for the differential immunodiagnosis of human Chagas'disease.
The importance of different mammalian species as reservoir hosts in American trypanosomiasis has been showed by several investigators6. As there area many areas in Central and South America in which Chagas' disease is coendemic with other trypanosoma tidae infections13 23, the detection of anticomponent 5 antibodies in wild reservoirs would be important for epidemiological purposes. Nevertheless, in the present study by using a highly sensitive technique, the CEIA, we were unable to find this antibody in opossums naturally infected with T. cruzi. In addition, dogs and rats experimentally infected with this parasite did not present significant levels of anti-component 5 antibo dies. Finally, the detection of lower levels of this antibody in some sera of rabbits infected with T. cruzi could not be confirmed by immunoelectrophoresis, a less sensitive technique.
In previous studies, Kirchhoff et al15 have shown that the expression of a surface antigen identi fied by a mAb differs among strains and clones of T. cruzi. This suggests that strain-specific immune res ponses can occur during the infection. Nevertheless, the anti-component 5 mAb generated against the Tehuantepec strain of T. cruzi19 also reacted with the 12 SF strain (Andrade et a l : in preparation) used here to infect dogs and rabbits. Moreover, in the present work, the rats were infected with the same strain used to produce the mAb. Therefore, the possibility of a strain-specific immune response against component 5 as an argument to explain the absence of anti-component 5 antibodies in dogs, rats and rabbits infected with T. cruzi is excluded. 
RESUMO
